Adverum Clinical Site 213 — Orlando, Florida

Adverum Clinical Site 213 is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 213 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Sponsors: Adverum Biotechnologies, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 213?

Adverum Clinical Site 213 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 213 conducted?

Adverum Clinical Site 213 has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Is Adverum Clinical Site 213 accredited by Crixeo Health?

Adverum Clinical Site 213 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 213?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.